Xeris Biopharma Holdings (XERS) Prepaid Assets (2020 - 2026)

Xeris Biopharma Holdings (XERS) has 7 years of Prepaid Assets data on file, last reported at $9.4 million in Q1 2026.

• Quarterly Prepaid Assets rose 55.83% year-over-year to $9.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.4 million (up 55.83% YoY) and the FY2025 annual result came in at $9.5 million, up 28.14% from the prior year.
• Prepaid Assets fell to $9.4 million in Q1 2026, from $9.5 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $11.2 million in Q3 2025 to a low of $5.1 million in Q1 2022.
• A 5-year average of $7.8 million and a median of $7.6 million in 2024 frame the typical range for Prepaid Assets.
• Annual changes were most pronounced in 2022 — Prepaid Assets jumped 119.07% — and 2023, when it tumbled 37.78%.
• Tracing XERS's Prepaid Assets over 5 years: stood at $9.3 million in 2022, then sank by 37.78% to $5.8 million in 2023, then increased by 28.95% to $7.5 million in 2024, then advanced by 28.14% to $9.5 million in 2025, then dropped by 1.52% to $9.4 million in 2026.
• The last three Prepaid Assets figures came in at $9.4 million (Q1 2026), $9.5 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.